Endo International PLC ENDO INTERNATIONAL ORD SHS
Endo International PLC ENDO INTER.../ IE00BJ3V9050 /
0Y5F
|
26/01/2023 15:46:04
|
Chg.
-
|
Volume |
Bid06:00:11 |
Demandez à06:00:11 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
0.1020USD
|
-
|
500
Chiffrre d'affaires: 51 |
-Bid taille: - |
-Ask la taille: - |
141,131.7672USD |
- |
- |
Description de l'entreprise
Endo International plc is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical and generic pharmaceutical products as well as over-the-counter medications though its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.
Conseil d'administration & Conseil de surveillance
| PDG |
| Blaise Coleman |
| Conseil d'administration |
| Mark Bradley, Dr. James P. Tursi, George Apostol, M.D., James Papp, Joseph A. Barbarite, Laure Park, Matthew J. Maletta, Patrick Barry, Robert Polke, Ruth Thorpe, Susan Williamson, Tracy Basso |
| Conseil de surveillance |
| Mark G. Barberio, Blaise Coleman, Dr. M. Christine Smith, Dr. Nancy J. Hutson, Jennifer M. Chao, Michael Hyatt, Shane M. Cooke, William P. Montague |
Données de l'entreprise
| Nom: |
Endo International Plc. |
| Adresse: |
First Floor, Minerva House, Simmonscourt Road,Ballsbridge, Dublin 4, Ireland |
| Téléphone: |
+11-353-1-268-200 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
www.endo.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
57.10% |
| IPO date: |
- |
Principaux actionnaires
| FreeFloat |
|
57.10% |
| BlackRock Inc. |
|
15.70% |
| The Vanguard Group, Inc. |
|
10.90% |
| Renaissance Technologies LLC |
|
8.40% |
| Paulson & Co., Inc. |
|
7.90% |
